A fluorometric assay to determine the protective effect of glucose-6-phosphate dehydrogenase (G6PD) against a Plasmodium spp. infection in females heterozygous for the G6PD gene: proof of concept in Plasmodium falciparum.


Journal

BMC research notes
ISSN: 1756-0500
Titre abrégé: BMC Res Notes
Pays: England
ID NLM: 101462768

Informations de publication

Date de publication:
22 Feb 2022
Historique:
received: 27 10 2021
accepted: 03 02 2022
entrez: 23 2 2022
pubmed: 24 2 2022
medline: 25 2 2022
Statut: epublish

Résumé

Glucose-6-phosphate dehydrogenase (G6PD) deficiency offers some protection against malaria; however, the degree of protection is poorly described and likely to vary with G6PD genotype and Plasmodium species. We present a novel approach to quantify the differential invasion rates of P. falciparum between G6PD deficient and normal red blood cells (RBCs) in an ex vivo model. A flow-cytometry based assay was developed to distinguish G6PD deficient and normal, parasitized and non-parasitized RBCs within the same sample. Venous blood collected from a G6PD heterozygous female was infected and cultured ex vivo with a laboratory strain of P. falciparum (FC27). Aliquots of infected blood were assayed at schizont and subsequent synchronized ring stages. At schizont stage, 84.9% of RBCs were G6PD deficient of which 0.4% were parasitized compared to 2.0% of normal RBCs. In the subsequent ring stage, 90.4% of RBCs were deficient and 0.2% of deficient and 0.9% of normal cells respectively were parasitized. The pooled Odds Ratio for a deficient RBC to be parasitized was 0.2 (95% confidence interval: 0.18-0.22, p < 0.001) compared to a normal cell. Further studies are warranted to explore preferential parasitization with different G6PD variants and Plasmodium species.

Identifiants

pubmed: 35193663
doi: 10.1186/s13104-022-05952-1
pii: 10.1186/s13104-022-05952-1
pmc: PMC8862483
doi:

Substances chimiques

G6PD protein, human EC 1.1.1.49
Glucosephosphate Dehydrogenase EC 1.1.1.49

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

76

Subventions

Organisme : Wellcome Trust
ID : 200909/Z/16/Z
Pays : United Kingdom
Organisme : Bill & Melinda Gates Foundation
ID : INV-007122
Pays : United States

Informations de copyright

© 2022. The Author(s).

Références

Science. 1969 May 16;164(3881):839-42
pubmed: 4889647
Malar J. 2018 Oct 19;17(1):371
pubmed: 30340592
Blood. 2008 Jan 1;111(1):16-24
pubmed: 18156501
N Engl J Med. 2021 May 27;384(21):2067-2069
pubmed: 34042394
Blood. 2020 Sep 10;136(11):1225-1240
pubmed: 32702756
Science. 1976 Aug 20;193(4254):673-5
pubmed: 781840
Acta Haematol. 2020;143(3):196-203
pubmed: 31550707
PLoS Med. 2021 May 26;18(5):e1003632
pubmed: 34038413
J Parasitol. 1979 Jun;65(3):418-20
pubmed: 383936
Sci Rep. 2012;2:299
pubmed: 22393475
Sci Rep. 2017 Apr 06;7:45963
pubmed: 28382932

Auteurs

Angela Rumaseb (A)

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Casuarina, PO Box 41096, Darwin, NT, 0811, Australia. Angela.rumaseb@menzies.edu.au.

Jutta Marfurt (J)

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Casuarina, PO Box 41096, Darwin, NT, 0811, Australia.

Steven Kho (S)

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Casuarina, PO Box 41096, Darwin, NT, 0811, Australia.

Maria Kahn (M)

PATH Diagnostics Group, Seattle, WA, USA.

Ric N Price (RN)

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Casuarina, PO Box 41096, Darwin, NT, 0811, Australia.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand.

Benedikt Ley (B)

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Casuarina, PO Box 41096, Darwin, NT, 0811, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH